Kaposi sarcoma herpesvirus-associated cancers and related diseases

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in HIV and AIDS

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/COH.0000000000000330PMID 27662501PMCID PMC6311702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).

  2016cited by this paper
• Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

  2016cited by this paper
• HIV and human herpesvirus 8 co‐infection across the globe: Systematic review and meta‐analysis

  2016cited by this paper
• NEDDylation Is Essential for Kaposi’s Sarcoma-Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target

  2015cited by this paper
• KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation

  2015cited by this paper
• Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors

  2015cited by this paper
• Multi-step regulation of innate immune signaling by Kaposi's sarcoma-associated herpesvirus.

  2015cited by this paper
• Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1

  2015cited by this paper
• Glutamate Secretion and Metabotropic Glutamate Receptor 1 Expression during Kaposi's Sarcoma-Associated Herpesvirus Infection Promotes Cell Proliferation

  2014cited by this paper
• Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.

  2014cited by this paper
• Pomalidomide Induces Expansion of Activated and Central Memory CD4+ and CD8+ T Cells in Vivo in Patients with and without HIV Infection

  2014cited by this paper
• Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.

  2014cited by this paper
• Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

  2014cited by this paper
• A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.

  2013cited by this paper
• Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

  2013cited by this paper
• KSHV MicroRNAs Mediate Cellular Transformation and Tumorigenesis by Redundantly Targeting Cell Growth and Survival Pathways

  2013cited by this paper
• mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis.

  2013cited by this paper
• Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.

  2012cited by this paper
• A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa

  2012cited by this paper
• Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

  2012cited by this paper
• Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome

  2012cited by this paper
• Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

  2012cited by this paper
• HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.

  2012cited by this paper
• High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

  2011cited by this paper
• HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer

  2011cited by this paper
• A Kaposi's Sarcoma-Associated Herpesvirus-Encoded Ortholog of MicroRNA miR-155 Induces Human Splenic B-Cell Expansion in NOD/LtSz-scid IL2Rγnull Mice

  2011cited by this paper
• An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

  2010cited by this paper
• Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma

  2010cited by this paper
• A Human Herpesvirus MicroRNA Inhibits p21 Expression and Attenuates p21-Mediated Cell Cycle Arrest

  2010cited by this paper
• The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

  2009cited by this paper
• Use of Saliva as a Lubricant in Anal Sexual Practices Among Homosexual Men

  2009cited by this paper
• Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma.

  2008cited by this paper
• Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells

  2008cited by this paper
• Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease

  2007cited by this paper
• A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.

  2007cited by this paper
• AIDS-related cancer and severity of immunosuppression in persons with AIDS.

  2007cited by this paper
• Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

  2007cited by this paper
• Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.

  2007cited by this paper
• Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.

  2007cited by this paper
• Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT Signaling

  2006cited by this paper
• Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.

  2006cited by this paper
• Trends in cancer risk among people with AIDS in the United States 1980–2002

  2006cited by this paper
• The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.

  2006cited by this paper
• The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.

  2006cited by this paper
• Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS.

  2005cited by this paper
• Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA.

  2005cited by this paper
• Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

  2005cited by this paper
• Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.

  2004cited by this paper
• KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells

  2004cited by this paper
• KSHV-Positive Solid Lymphomas Represent an Extra-Cavitary Variant of Primary Effusion Lymphoma

  2004cited by this paper
• The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Activates the Akt Signaling Pathway

  2004cited by this paper
• AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.

  2003cited by this paper
• Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways

  2003cited by this paper
• Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.

  2002cited by this paper
• Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma

  2002cited by this paper
• Efficacy of Low-Dose Interferon with Antiretroviral Therapy in Kaposi's Sarcoma: A Randomized Phase II AIDS Clinical Trials Group Study

  2002cited by this paper
• Pleural and Peritoneal Lymphoma Among People With AIDS in the United States

  2002cited by this paper
• Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.

  2002cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53

  2001cited by this paper
• Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus.

  2001cited by this paper
• Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.

  2001cited by this paper
• Kaposi ’ s Sarcoma-Associated Herpesvirus LANA 2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p 53

  2000cited by this paper
• Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis

  2000cited by this paper
• Mucosal shedding of human herpesvirus 8 in men.

  2000cited by this paper
• Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells.

  2000cited by this paper
• Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study.

  2000cited by this paper
• High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

  2000cited by this paper
• Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.

  2000cited by this paper
• Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men.

  2000cited by this paper
• Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.

  1999cited by this paper
• p53 inhibition by the LANA protein of KSHV protects against cell death

  1999cited by this paper
• The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

  1999cited by this paper
• Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

  1999cited by this paper
• Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

  1998cited by this paper
• Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.

  1998cited by this paper
• The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic.

  1998cited by this paper
• γ-Interferon Production in Peripheral Blood Mononuclear Cells and Tumor Infiltrating Lymphocytes From Kaposi's Sarcoma Patients: Correlation With the Presence of Human Herpesvirus-8 in Peripheral Blood Mononuclear Cells and Lesional Macrophages

  1998cited by this paper
• Sexual transmission and the natural history of human herpesvirus 8 infection.

  1998cited by this paper
• Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

  1998cited by this paper
• Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

  1998cited by this paper
• gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages.

  1998cited by this paper
• AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.

  1997cited by this paper
• Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates.

  1997cited by this paper
• Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients

  1996cited by this paper
• Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

  1996cited by this paper
• Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

  1996cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

  1995cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• Association of Kaposi's sarcoma and prior immunosuppressive therapy. A 5‐year material of Kaposi's sarcoma in Norway

  1978cited by this paper

• Targeting of Kaposi’s sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74

  2026cites this paper
• Enfermedad de Kaposi

  2026cites this paper
• The pathogen’s playbook in cancer: from oncogenesis to progression

  2026cites this paper
• Viral Reprogramming of Nucleotide Synthesis and Its Impact on Viral Infection

  2025cites this paper
• Heterogeneous Activation of Signaling Pathways and Therapeutic Vulnerabilities in KSHV‐Associated Primary Effusion Lymphoma Cell Lines

  2025influential citation
• Epidemiology, molecular typing, microbiome-immune interactions and treatment strategies of endometrial cancer: a review

  2025cites this paper
• Tumor Necrosis Factor Receptor-Associated Factors (TRAFs): Key Regulatory Factors in Antiviral Defence.

  2025cites this paper
• Formation of Polyploid Giant Cancer Cells and the Transformative Role of Human Cytomegalovirus IE1 Protein.

  2025cites this paper
• Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon

  2025cites this paper
• Kaposi sarcoma herpesvirus (KSHV) inflammatory cytokine syndrome (KICS): a case study

  2025cites this paper
• Heat shock factor 2 regulates oncogenic gamma-herpesvirus gene expression by remodeling the chromatin at the ORF50 and BZLF1 promoter

  2025cites this paper
• How herpes is assembled

  2025cites this paper
• Noncutaneous Visceral Kaposi Sarcoma of the Stomach and Liver: A Case Report

  2025cites this paper
• Viral interference of nucleocytoplasmic transport

  2025cites this paper
• The Kaposi’s sarcoma-associated herpesvirus TBP mimic uses a noncanonical DNA-binding mode to promote viral late gene transcription

  2025cites this paper
• Maladie de Kaposi

  2025cites this paper
• The Kaposi’s sarcoma-associated herpesvirus TBP mimic uses a non-canonical DNA binding mode to promote viral late gene transcription

  2025cites this paper
• The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer

  2024cites this paper
• RNA Modifications and Their Role in Regulating KSHV Replication and Pathogenic Mechanisms

  2024cites this paper
• Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review

  2024cites this paper
• The ‘Oma’s of the Gammas—Cancerogenesis by γ-Herpesviruses

  2024cites this paper
• Structural insights into KSHV-GPCR constitutive activation and CXCL1 chemokine recognition

  2024cites this paper
• In vitro and in vivo evidence of the antineoplastic activity of quercetin against endothelial cells transformed by Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.

  2024cites this paper
• KSHV ORF20 Promotes Coordinated Lytic Reactivation for Increased Infectious Particle Production

  2024cites this paper
• Comparison of IL-6, IL-10, and TNFα Levels Between PLWHIV With and Without Kaposi Sarcoma and Healthy Controls

  2024cites this paper
• Introduction to Nutrition and Cancer.

  2024cites this paper
• Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases

  2024cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• KSHV 3.0: a state-of-the-art annotation of the Kaposi’s sarcoma-associated herpesvirus transcriptome using cross-platform sequencing

  2024cites this paper
• miR-769-3p inhibits cellular proliferation of KSHV-infected SH-SY5Y cells through targeting mTOR

  2024cites this paper
• Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level

  2024cites this paper
• Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden

  2024cites this paper
• The role of viruses in cancer progression versus cancer treatment: A dual paradigm.

  2024cites this paper
• KSHV genome harbors both constitutive and lytically induced enhancers

  2024cites this paper
• Tim-1 and Tim-4 mediate entry of the human Kaposi’s sarcoma-associated herpesvirus and the related rhesus monkey rhadinovirus

  2024cites this paper
• Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages

  2023cites this paper
• Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation

  2023cites this paper
• Parthenolide inhibits proliferation of cells infected with Kaposi’s sarcoma-associated herpesvirus by suppression of the NF-κB signaling pathway

  2023cites this paper
• KSHV 3.0: A State-of-the-Art Annotation of the Kaposi’s Sarcoma-Associated Herpesvirus Transcriptome Using Cross-Platform Sequencing

  2023cites this paper
• The impact of HLA polymorphism on herpesvirus infection and disease

  2023cites this paper
• Antimicrobial Properties of Capsaicin: Available Data and Future Research Perspectives

  2023cites this paper
• Conjunctival Kaposi's Sarcoma as an Initial Diagnosis of AIDS

  2023cites this paper
• Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis

  2023cites this paper
• Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation

  2023cites this paper
• A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome

  2023cites this paper
• Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases

  2023cites this paper
• The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host–Pathogen Interactions

  2023cites this paper
• Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute Plasmodium falciparum Malaria Episodes

  2023cites this paper
• Kaposi’s sarcoma-associated herpesvirus glycoprotein K8.1 is critical for infection in a cell-specific manner and functions at the attachment step on keratinocytes

  2023cites this paper
• KSHV uses viral IL6 to expand infected immunosuppressive macrophages

  2023cites this paper
• The role of viruses in cancer development versus cancer therapy: An oncological perspective

  2023cites this paper
• Direct and biologically significant interactions of human herpesvirus 8 interferon regulatory factor 1 with STAT3 and Janus kinase TYK2

  2023cites this paper
• The Debate between the Human Microbiota and Immune System in Treating Aerodigestive and Digestive Tract Cancers: A Review

  2023cites this paper
• Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency In Vivo

  2022cites this paper
• Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.

  2022cites this paper
• Flavonoids Target Human Herpesviruses That Infect the Nervous System: Mechanisms of Action and Therapeutic Insights

  2022cites this paper
• Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma

  2022cites this paper
• Metatranscriptomics Analysis Reveals Diverse Viral RNA in Cutaneous Papillomatous Lesions of Cattle

  2022cites this paper
• Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies

  2022cites this paper
• Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers—A Focus on EBV and KSHV Life Cycles and Carcinogenesis

  2022cites this paper
• Primaquine as a Candidate for HHV-8-Associated Primary Effusion Lymphoma and Kaposi’s Sarcoma Treatment

  2022cites this paper
• Topological implications of DNA tumor viral episomes

  2022cites this paper
• Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses

  2022cites this paper
• L’herpèsvirus humain 8

  2022cites this paper
• High-Risk Oncogenic Human Cytomegalovirus

  2022cites this paper
• Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases

  2022cites this paper
• Chlamydia Trachomatis Infection: Their potential implication in the Etiology of Cervical Cancer

  2021cites this paper
• Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders

  2021cites this paper
• Novel Functions and Virus-Host Interactions Implicated in Pathogenesis and Replication of Human Herpesvirus 8.

  2021cites this paper
• Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

  2021cites this paper
• The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients

  2021cites this paper
• HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi’s Sarcoma-Associated Herpesvirus

  2021cites this paper
• The Portal Vertex of KSHV Promotes Docking of Capsids at the Nuclear Pores

  2021cites this paper
• Inhibition of Host Gene Expression by KSHV: Sabotaging mRNA Stability and Nuclear Export

  2021cites this paper
• Industrializing engineered autologous T cells as medicines for solid tumours

  2021cites this paper
• iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release

  2021cites this paper
• Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi’s Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties

  2021cites this paper
• Rab27b regulates extracellular vesicle production in cells infected with Kaposi’s sarcoma-associated herpesvirus to promote cell survival and persistent infection

  2021cites this paper
• STINGing Viral Tumors: What We Know from Head and Neck Cancers

  2021influential citation
• HMGB1 Knockout Decreases Kaposi's Sarcoma-Associated Herpesvirus Virion Production in iSLK BAC16 Cells by Attenuating Viral Gene Expression

  2021cites this paper
• Anticancer activities of parthenolide in primary effusion lymphoma preclinical models

  2021cites this paper
• What to Do for Increasing Cancer Burden on the African Continent? Accelerating Public Health Diagnostics Innovation for Prevention and Early Intervention on Cancers

  2021cites this paper
• Activation and evasion of innate immunity by gammaherpesviruses.

  2021cites this paper
• Establishing the Role of DC-SIGN and Glycoprotein H for KSHV Entry in B Lymphocytes

  2021cites this paper
• Oral Kaposi sarcoma development is associated with HIV viral load, CD4+ count and CD4+/CD8+ ratio

  2021cites this paper
• Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV

  2021cites this paper
• Potential entry receptors for human γ-herpesvirus into epithelial cells: A plausible therapeutic target for viral infections

  2021cites this paper
• The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options

  2020cites this paper
• Targeting the Kaposi’s sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells

  2020cites this paper
• Dualism of Viruses in Oncology

  2020cites this paper
• Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders.

  2020cites this paper
• A Fatal Case of Kaposi Sarcoma Immune Reconstitution Syndrome (KS-IRIS) Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) or Multicentric Castleman Disease (MCD): A Case Report and Review

  2020influential citation
• Causes of cancer: physical, chemical, biological carcinogens, and viruses

  2020cites this paper
• Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome

  2020cites this paper
• Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples.

  2020cites this paper
• Clinical and pathological features of kaposi sarcoma herpesvirus inflammatory cytokine syndrome: case report and review of the literature.

  2020cites this paper
• Kaposi’s sarcoma-associated herpesvirus related malignancy in India, a rare but emerging member to be considered

  2020cites this paper
• Polyploid Giant Cancer Cells, a Hallmark of Oncoviruses and a New Therapeutic Challenge

  2020cites this paper
• The Sub-Nuclear Localization of RNA-Binding Proteins in KSHV-Infected Cells

  2020cites this paper
• KSHV-encoded vCyclin can modulate HIF1α levels to promote DNA replication in hypoxia

  2020cites this paper